Weber Kam Onn Lau

Learn More
Background:This study was performed to report the prevalence of lower urinary tract symptoms (LUTSs), bother and related quality of life (QOL) and health-seeking behaviour in men 40 years old or older in Singapore.Methods:The study was a community-based, cross-sectional study targeting males 40 years and above in the township of Bedok North, Singapore. An(More)
Among the aims of the 2nd Conference on Asian Trends in Prostate Cancer Hormone Therapy, Hong Kong, December 7-8, 2002, was to lay the groundwork for eventually having cooperative or collaborative studies of prostate cancer specifically in Asian patients. The conference was divided into 2 sessions. In the first session, entitled "Current Status of Therapy(More)
BACKGROUND Using sextant biopsy, 16-41% of prostate cancers were diagnosed on repeat biopsy. The objective of the present study was to compare the differences in the clinical, biochemical and pathological features between patients with positive results on initial and repeat biopsies, with an aim to identify factors that can be used to improve the detection(More)
BACKGROUND Enzalutamide is an androgen receptor (AR) inhibitor that acts on different steps in the AR signaling pathway. In PREVAIL, an international, phase III, double-blind, placebo-controlled trial, enzalutamide significantly reduced the risk of radiographic progression by 81% (hazard ratio [HR], 0.19; P < .0001) and reduced the risk of death by 29% (HR,(More)
  • 1